SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-035530
Filing Date
2021-07-02
Accepted
2021-07-02 16:00:28
Documents
2
Period of Report
2021-07-02
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea143657-8k_orionbiotech.htm 8-K 21010
2 PRESS RELEASE, DATED JULY 1, 2021. ea143657ex99-1_orionbiotech.htm EX-99.1 9262
  Complete submission text file 0001213900-21-035530.txt   31341
Mailing Address 645 FIFTH AVENUE, 21ST FLOOR NEW YORK NY 10022
Business Address 645 FIFTH AVENUE, 21ST FLOOR NEW YORK NY 10022 212-303-7822
Orion Biotech Opportunities Corp. (Filer) CIK: 0001847416 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40410 | Film No.: 211069806
SIC: 6770 Blank Checks